Literature DB >> 4363108

Physiocochemical properties of low-density lipoproteins of normal human plasma. Evidence for the occurrence of lipoprotein B in associated and free forms.

D M Lee, P Alaupovic.   

Abstract

1. Low-density (d 1.006-1.063g/ml) lipoproteins from normal human plasma were separated by differential preparative ultracentrifugation into six subfractions. Each low-density (LD) lipoprotein subfraction contained lipoprotein B as the major and lipoproteins A and C as the minor lipoprotein families. 2. Three lipoprotein B subfractions (LP-B), LP-B-III (d 1.019-1.030g/ml), LP-B-IV (d 1.030-1.040g/ml) and LP-B-V (d 1.040-1.053g/ml) were prepared from the corresponding LD lipoprotein subfractions by immunoprecipitating small amounts of lipoproteins A and C. 3. Determination of hydrodynamic properties indicated that LD lipoproteins consisted of three molecular segments characterized by a stepwise change in the molecular weight: LDL-I and LDL-II subfractions (d 1.006-1.019g/ml) with an average mol.wt. of 4.75x10(6), LDL-III (d 1.019-1.030g/ml) with a mol.wt. of 3.99x10(6), and LDL-IV, LDL-V and LDL-VI (d 1.030-1.063g/ml) with a mol.wt. of 2.85x10(6). 4. All three lipoprotein B subfractions had an average mol.wt. of 3.16x10(6). 5. The LDL-I and LDL-II subfractions consisted of lipoprotein B and lipoprotein C families which were present in the form of an association complex. This was isolated from serum by immunoprecipitation with antibodies to lipoprotein B. The complex had a mol.wt. of 4.35x10(6). 6. The results indicate a fundamental difference between the LD lipoprotein subfractions with d 1.006-1.019g/ml and those subfractions with d 1.030-1.063g/ml. In the former, lipoprotein B occurs as a part of an association complex, whereas in the latter it occurs as a separate entity.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4363108      PMCID: PMC1166101          DOI: 10.1042/bj1370155

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  The dissociation in vitro of the alpha- and beta-lipoprotein components of human and rat very low density lipoproteins.

Authors:  A I Kook; A S Eckhaus; D Rubinstein
Journal:  Can J Biochem       Date:  1970-06

Review 2.  Human serum lipoproteins and their interrelationships.

Authors:  A V Nichols
Journal:  Adv Biol Med Phys       Date:  1967

Review 3.  The analysis of human serum lipoprotein distributions.

Authors:  A M Ewing; N K Freeman; F T Lindgren
Journal:  Adv Lipid Res       Date:  1965

4.  A method for the isolation of antibodies to human beta 1-lipoprotein.

Authors:  G Kostner; A Holasek
Journal:  Biochim Biophys Acta       Date:  1969-08-12

5.  Flotation rates, molecular weights and hydrated densities of the low-density lipoproteins.

Authors:  F T Lindgren; L C Jensen; R D Wills; N K Freeman
Journal:  Lipids       Date:  1969-09       Impact factor: 1.880

6.  Polydispersity of human low-density lipoproteins.

Authors:  G H Adams; V N Schumaker
Journal:  Ann N Y Acad Sci       Date:  1969-11-07       Impact factor: 5.691

7.  Hydrodynamic studies of human low density lipoproteins. Evaluation of the diffusion coefficient and the preferential hydration.

Authors:  W R Fisher; M E Granade; J L Mauldin
Journal:  Biochemistry       Date:  1971-04-27       Impact factor: 3.162

8.  Studies of the composition and structure of plasma lipoproteins. Isolation, composition, and immunochemical characterization of low density lipoprotein subfractions of human plasma.

Authors:  D M Lee; P Alaupovic
Journal:  Biochemistry       Date:  1970-05-26       Impact factor: 3.162

9.  Properties of human serum low density lipoproteins after modification by succinic anhydride.

Authors:  A Scanu; H Pollard; W Reader
Journal:  J Lipid Res       Date:  1968-05       Impact factor: 5.922

10.  Reversible thermal conformation changes in human serum low-density lipoprotein.

Authors:  D G Dearborn; D B Wetlaufer
Journal:  Proc Natl Acad Sci U S A       Date:  1969-01       Impact factor: 11.205

View more
  9 in total

1.  Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins.

Authors:  Stéphanie Bonneau; Christine Vever-Bizet; Patrice Morlière; Jean-Claude Mazière; Daniel Brault
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

2.  Evidence for the lipoprotein heterogeneity of human plasma high density lipoproteins isolated by three different procedures.

Authors:  A Suenram; W J McConathy; P Alaupovic
Journal:  Lipids       Date:  1979-05       Impact factor: 1.880

3.  Incubation of lipid emulsions with plasma lipoproteins modifies the fluidity of each particle.

Authors:  N F Chanson; J F Lontie; Y A Carpentier; C Motta
Journal:  Lipids       Date:  2001-08       Impact factor: 1.880

4.  Sedimentation equilibrium of human low density lipoprotein subfractions.

Authors:  T S Kahlon; G L Adamson; M M Shen; F T Lindgren
Journal:  Lipids       Date:  1982-05       Impact factor: 1.880

5.  LDL binding to lipid emulsion particles: effects of incubation duration, temperature, and addition of plasma subfractions.

Authors:  Nathalie F Chanson; Jean-François Lontie; Annette Gulik; Jacqueline Férézou; Yvon A Carpentier
Journal:  Lipids       Date:  2002-06       Impact factor: 1.880

Review 6.  [Lipid-protein-interactions of human apolipoproteins-structural aspects and models of lipoproteins (author's transl)].

Authors:  G Middelhoff; J Augustin; G Klose; H Greten
Journal:  Klin Wochenschr       Date:  1977-02-15

7.  The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide.

Authors:  B J Van Lenten; A M Fogelman; M E Haberland; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

8.  Investigation of the abnormal low-density lipoproteins occurring in patients with obstructive jaundice.

Authors:  G M Kostner; P Laggner; H J Prexl; A Holasek
Journal:  Biochem J       Date:  1976-08-01       Impact factor: 3.857

9.  Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein.

Authors:  F V Chisari; T S Edgington
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.